Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-14-070778
Filing Date
2014-11-25
Accepted
2014-11-25 07:35:31
Documents
15
Period of Report
2014-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v395164_6k.htm 6-K 114687
2 GRAPHIC image_001.jpg GRAPHIC 2946
3 GRAPHIC image_004.jpg GRAPHIC 105784
4 GRAPHIC image_005.jpg GRAPHIC 145842
5 GRAPHIC image_006.jpg GRAPHIC 178555
6 GRAPHIC image_007.jpg GRAPHIC 86835
7 GRAPHIC image_008.jpg GRAPHIC 59529
8 GRAPHIC image_009.jpg GRAPHIC 129850
9 GRAPHIC image_010.jpg GRAPHIC 112749
10 GRAPHIC image_011.jpg GRAPHIC 77788
11 GRAPHIC image_012.jpg GRAPHIC 113674
12 GRAPHIC image_013.jpg GRAPHIC 18819
13 GRAPHIC image_014.jpg GRAPHIC 111716
14 GRAPHIC image_015.jpg GRAPHIC 160962
15 GRAPHIC image_016.jpg GRAPHIC 21595
  Complete submission text file 0001144204-14-070778.txt   1945504
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 141247785
SIC: 2834 Pharmaceutical Preparations